Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bonnefont-Rousselot

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Journal of Clinical Lipidology|August 7, 2023
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemiaMaryam Darabi, Marie Lhomme, Maharajah Ponnaiah, et al.
Human Mutation|September 6, 2012
Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutationMarie Marduel, Khadija Ouguerram, Valérie Serre, et al.
Plos One|December 30, 2017
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.
Plos One|November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
Cardiovascular Diabetology|September 19, 2020
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort studyOlivier Bourron, Franck Phan, Mamadou Hassimiou Diallo, et al.
Plos One|August 21, 2012
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyHelmi M'Kada, Hugo Perazzo, Mona Munteanu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 9, 2019
Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trialClotilde Mircher, Silvia Sacco, Charles Bouis, et al.
Journal of Neurology|February 17, 2026
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapyCharleen Robert, Dimitri Psimaras, Sylvain Choquet, et al.
Neurobiology of Disease|April 1, 2023
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progressionWalid Khrouf, Dario Saracino, Benoit Rucheton, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Journal of Clinical Lipidology|August 7, 2023
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemiaMaryam Darabi, Marie Lhomme, Maharajah Ponnaiah, et al.
Human Mutation|September 6, 2012
Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutationMarie Marduel, Khadija Ouguerram, Valérie Serre, et al.
Plos One|December 30, 2017
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.
Plos One|November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
Cardiovascular Diabetology|September 19, 2020
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort studyOlivier Bourron, Franck Phan, Mamadou Hassimiou Diallo, et al.
Plos One|August 21, 2012
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyHelmi M'Kada, Hugo Perazzo, Mona Munteanu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 9, 2019
Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trialClotilde Mircher, Silvia Sacco, Charles Bouis, et al.
Journal of Neurology|February 17, 2026
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapyCharleen Robert, Dimitri Psimaras, Sylvain Choquet, et al.
Neurobiology of Disease|April 1, 2023
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progressionWalid Khrouf, Dario Saracino, Benoit Rucheton, et al.
Pageof 16